Skip to main content
. 2015 Jun 26;2:10.3402/ecrj.v2.26721. doi: 10.3402/ecrj.v2.26721

Table 4.

A summary of the longitudinal case reports concerning lung involvement in Fabry disease

Ref. no. and year of publ. No. of patients Methods Outcome Conclusion
(5) 2008 One female Spirometry, biochemistry, X-ray, CT scan, open lung biopsy, initiation of ERT Mixed restrictive/obstructive pattern, patchy ground-glass infiltrations, peribronchiolar fibrosis, and smooth-muscle cell hyperplasia. Inclusion bodies. ERT stabilised the airway obstruction Pulmonary involvement is due to lysosomal storage on cells. Treatment with ERT was able to stabilise the airway obstruction
(8) 2007 One female Biochemistry, spirometry, ventilation-perfusion scan, echocardiography, CT scan. Initiation of ERT LVH, reduced diffusion capacity, a combination of ground-glass infiltrations and air trapping. Improvement of pulmonary signs but persisting opacities and air trapping after ERT ERT might improve pulmonary signs but has no effect on ground-glass infiltrations and air trapping found on CT scan
(18) 2013 One female Spirometry, renal biopsy, lung biopsy, biochemistry, electron microscopy Patient with the diagnosis of COPD received a lung transplant. Later, Fabry disease was diagnosed Rare differential diagnosis might be hidden under more common diseases. Respiratory impairment cannot be denied

All studies included physical examination and interview about past medical history.

ERT, enzyme replacement therapy; LVH, left ventricular hypertrophy; COPD, chronic obstructive pulmonary disease.